Cargando…

The Contribution of Lysosomotropism to Autophagy Perturbation

Autophagy refers to the catabolic process in eukaryotic cells that delivers cytoplasmic material to lysosomes for degradation. This highly conserved process is involved in the clearance of long-lived proteins and damaged organelles. Consequently, autophagy is important in providing nutrients to main...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ashoor, Roshan, Yafawi, Rolla, Jessen, Bart, Lu, Shuyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3838419/ https://www.ncbi.nlm.nih.gov/pubmed/24278483 http://dx.doi.org/10.1371/journal.pone.0082481

Ejemplares similares

Lysosomal adaptation: How cells respond to lysosomotropic compounds
por: Lu, Shuyan, et al.
Publicado: (2017)

Akt inhibition promotes autophagy and sensitizes PTEN-null tumors to lysosomotropic agents
por: Degtyarev, Michael, et al.
Publicado: (2008)

Cell killing by lysosomotropic detergents
Publicado: (1983)

Identification of ML-9 as a lysosomotropic agent targeting autophagy and cell death
por: Kondratskyi, A, et al.
Publicado: (2014)

Image‐Based Morphological Profiling Identifies a Lysosomotropic, Iron‐Sequestering Autophagy Inhibitor
por: Laraia, Luca, et al.
Publicado: (2020)

Lysosomotropic agents as HCV entry inhibitors
por: Ashfaq, Usman A, et al.
Publicado: (2011)

Lysosomotropic Features and Autophagy Modulators among Medical Drugs: Evaluation of Their Role in Pathologies
por: Korolenko, Tatiana A., et al.
Publicado: (2020)

Lysosomotropism depends on glucose: a chloroquine resistance mechanism
por: Gallagher, Laura E, et al.
Publicado: (2017)

The lysosomotrope GPN mobilises Ca(2+) from acidic organelles
por: Yuan, Yu, et al.
Publicado: (2021)

Resistance to lysosomotropic drugs used to treat kidney and breast cancers involves autophagy and inflammation and converges in inducing CXCL5
por: Giuliano, Sandy, et al.
Publicado: (2019)

The lysosomotropic drug LeuLeu-OMe induces lysosome disruption and autophagy-independent cell death in Trypanosoma brucei
por: Koh, Hazel X., et al.
Publicado: (2015)

Recycling of the asialoglycoprotein receptor and the effect of lysosomotropic amines in hepatoma cells
Publicado: (1984)

A Novel Family of Lysosomotropic Tetracyclic Compounds for Treating Leukemia
por: Carbó, José M., et al.
Publicado: (2023)

QSAR Models for Predicting Five Levels of Cellular Accumulation of Lysosomotropic Macrocycles
por: Norinder, Ulf, et al.
Publicado: (2019)

Simulation-based cheminformatic analysis of organelle-targeted molecules: lysosomotropic monobasic amines
por: Zhang, Xinyuan, et al.
Publicado: (2008)

The role of lysosomal enzymes in killing of mammalian cells by the lysosomotropic detergent N-dodecylimidazole
Publicado: (1987)

Lysosomotropic agents including azithromycin, chloroquine and hydroxychloroquine activate the integrated stress response
por: Tian, Ai-Ling, et al.
Publicado: (2021)

Lysosomotropic Properties of Weakly Basic Anticancer Agents Promote Cancer Cell Selectivity In Vitro
por: Ndolo, Rosemary A., et al.
Publicado: (2012)

Lysosomotropic REV-ERB antagonism: A metabolic connection between circadian rhythm and autophagy may tell cancer cells “it's time to die”
por: Grimaldi, Benedetto
Publicado: (2014)

GUCY2C lysosomotropic endocytosis delivers immunotoxin therapy to metastatic colorectal cancer
por: Marszalowicz, Glen P., et al.
Publicado: (2014)

Existing highly accumulating lysosomotropic drugs with potential for repurposing to target COVID-19
por: Norinder, Ulf, et al.
Publicado: (2020)

Effect of lysosomotropic amines on the secretory pathway and on the recycling of the asialoglycoprotein receptor in human hepatoma cells
Publicado: (1985)

Destruction of Leishmania mexicana amazonensis amastigotes within macrophages by lysosomotropic amino acid esters
Publicado: (1986)

Lysosomotropic challenge of mast cells causes intra-granular reactive oxygen species production
por: Paivandy, Aida, et al.
Publicado: (2019)

The Lysosomotropic Activity of Hydrophobic Weak Base Drugs is Mediated via Their Intercalation into the Lysosomal Membrane
por: Stark, Michal, et al.
Publicado: (2020)

Initial events in bovine coronavirus infection: analysis through immunogold probes and lysosomotropic inhibitors
por: Payne, H. R., et al.
Publicado: (1990)

Effect of the lysosomotropic agent chloroquine on mTORC1 activation and protein synthesis in human skeletal muscle
por: Borack, Michael S., et al.
Publicado: (2021)

Targeting of VPS18 by the lysosomotropic agent RDN reverses TFE3-mediated drug resistance
por: Niu, Huanmin, et al.
Publicado: (2021)

Upregulation of DR5 and Downregulation of Survivin by IITZ-01, Lysosomotropic Autophagy Inhibitor, Potentiates TRAIL-Mediated Apoptosis in Renal Cancer Cells via Ubiquitin-Proteasome Pathway
por: Shahriyar, Sk Abrar, et al.
Publicado: (2020)

Pharmacophore hybridisation and nanoscale assembly to discover self-delivering lysosomotropic new-chemical entities for cancer therapy
por: Ma, Zhao, et al.
Publicado: (2020)

Lysosomotropic drugs activate TFEB via lysosomal membrane fluidization and consequent inhibition of mTORC1 activity
por: Zhitomirsky, Benny, et al.
Publicado: (2018)

Inhibition of JNK increases the sensitivity of hepatocellular carcinoma cells to lysosomotropic drugs via LAMP2A destabilization
por: Desideri, Enrico, et al.
Publicado: (2021)

Interactions of the Lysosomotropic Detergent O-Methyl-Serine Dodecylamide Hydrochloride (MSDH) with Lipid Bilayer Membranes—Implications for Cell Toxicity
por: Villamil Giraldo, Ana-Maria, et al.
Publicado: (2020)

Design of Protease Activated Optical Contrast Agents That Exploit a Latent Lysosomotropic Effect for Use in Fluorescence-Guided Surgery
por: Ofori, Leslie O., et al.
Publicado: (2015)

COVID-19/SARS-CoV-2 Infection: Lysosomes and Lysosomotropism Implicate New Treatment Strategies and Personal Risks
por: Blaess, Markus, et al.
Publicado: (2020)

Author Correction: Pharmacophore hybridisation and nanoscale assembly to discover self-delivering lysosomotropic new-chemical entities for cancer therapy
por: Ma, Zhao, et al.
Publicado: (2021)

Prostate Cancer Cells Are Sensitive to Lysosomotropic Agent Siramesine through Generation Reactive Oxygen Species and in Combination with Tyrosine Kinase Inhibitors
por: Garcia, Emily A., et al.
Publicado: (2022)

Drug triggered pruritus, rash, papules, and blisters – is AGEP a clash of an altered sphingolipid-metabolism and lysosomotropism of drugs accumulating in the skin?
por: Blaess, Markus, et al.
Publicado: (2021)

1-Benzyl-3-cetyl-2-methylimidazolium Iodide (NH125) Is a Broad-Spectrum Inhibitor of Virus Entry with Lysosomotropic Features
por: Moeschler, Sarah, et al.
Publicado: (2018)

Drugs, Metabolites, and Lung Accumulating Small Lysosomotropic Molecules: Multiple Targeting Impedes SARS-CoV-2 Infection and Progress to COVID-19
por: Blaess, Markus, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tqevipoionn5pchdg4jpd5eajh